ACTA1 and chronic obstructive pulmonary disease: Compared to cells derived from non-disease donors (n = 3), ASMCs derived from COPD patients (n = 6) showed lower expression of α-SMA (47.3%) and collagen type-I (32.9%), while the expression of fibronectin was significantly higher (262.9%) (Figure 1A).